PEMETREXED DITROMETHAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Pemetrexed Ditromethamine patents expire, and when can generic versions of Pemetrexed Ditromethamine launch?
Pemetrexed Ditromethamine is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in PEMETREXED DITROMETHAMINE is pemetrexed ditromethamine. There is one drug master file entry for this compound. Additional details are available on the pemetrexed ditromethamine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PEMETREXED DITROMETHAMINE?
- What are the global sales for PEMETREXED DITROMETHAMINE?
- What is Average Wholesale Price for PEMETREXED DITROMETHAMINE?
Summary for PEMETREXED DITROMETHAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PEMETREXED DITROMETHAMINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PEMETREXED DITROMETHAMINE
US Patents and Regulatory Information for PEMETREXED DITROMETHAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | PEMETREXED DITROMETHAMINE | pemetrexed ditromethamine | POWDER;INTRAVENOUS | 208746-003 | Jun 10, 2022 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | PEMETREXED DITROMETHAMINE | pemetrexed ditromethamine | POWDER;INTRAVENOUS | 208746-001 | Jun 10, 2022 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | PEMETREXED DITROMETHAMINE | pemetrexed ditromethamine | POWDER;INTRAVENOUS | 208746-002 | Jun 10, 2022 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
